Pioneering a quantitative,
precision-based approach to
disease diagnosis and treatment.
Patented molecular signatures
To discover disease presence at an individual level, our science identifies biological signatures composed of biomarkers that are accurate and disease-specific.
Quantitative diagnosis
Our quantitative rapid point-of-care test technology provides easily accessible, cost-effective tools for disease detection and response to therapy. Our disease areas of focus include:
Maternal health
- Preeclampsia
- Gestational diabetes
Diabetes
- Type 1
- Type 2
Autoimmune
- Rheumatoid arthritis
- COVID antibodies
Therapeutic efficacy
Our technology enables pharmaceutical companies to better assess the efficacy of targeted therapies.
Drug development strategies
We can help pharmaceutical companies to develop enhanced therapies for targeted diseases.